Skip to content

MACQS

Active
Private limited companyfounded 2023active for 3 yearsChaussée de Tirlemont(Jod.) 74, 1370 Jodoigne, BelgiumKBO/BCE: BE 0805.857.390
Summary

MACQS has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,096 and a net result of €33,487. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 32% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€272,657total assets 2025
Equity
€110,096
Profit
€33,487
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 18 days late1 deed in the Belgian Official Gazette
Why 93raises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 18-08-2026)Liquidity: current ratio 1.93, cash €40,123Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 46% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 65+13
equity 40.4% of total assets
Liquidity 62+9
short-term debt 19.9% · cash 14.7%
Profitability 84-3
return on assets 12.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.3 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.93, compared with 1.24 in 2024, above the usual 1.5; short-term debt: 19.9% and cash: 14.7% of total assets), but 59.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 33% on solvency, 40% on liquidity, 34% on profitability and 78% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 18-08-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.93, cash €40,123
NBB · annual accounts
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
18 days late
2024
27 days late
2023
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 8 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 August (3 of the last 3 filed years within 39 days of that day).
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €100,000equity €110,096 ▲43.7%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

2025 annual accounts filed late (18 days) Filed on 18 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00422084.

Equity
€110,096▲ 43.7%
2024 · €76,609
Total assets
€272,657▼ 3.7%
2024 · €283,087
Net result
€33,487▼ 18.2%
2024 · €40,929
Working capital
€50,615▲ 374%
2024 · €10,678
Trend over the years

2023 to 2025, 3 financial years

The operating result falls in 2025; 2025 is 12% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€49,692 2025 Net result€33,487 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€40,224-€56,306▲ 40.0%€49,692▼ 11.7%
Net result€31,680within the sector's middle half-€40,929within the sector's middle half▲ 29.2%€33,487within the sector's middle half▼ 18.2%
Equity€35,680below the sector's middle half-€76,609within the sector's middle half▲ 115%€110,096within the sector's middle half▲ 43.7%
Total assets€232,231within the sector's middle half-€283,087within the sector's middle half▲ 21.9%€272,657within the sector's middle half▼ 3.7%
Debt€196,551-€206,478▲ 5.1%€162,562▼ 21.3%
Working capital€27,178within the sector's middle half-€10,678below the sector's middle half▼ 60.7%€50,615within the sector's middle half▲ 374%
Solvency15.4%below the sector's middle half-27.1%below the sector's middle half▲ 11.7pp40.4%within the sector's middle half▲ 13.3pp
Current ratio4.57within the sector's middle half-1.24below the sector's middle half▼ 3.331.93within the sector's middle half▲ 0.69
Return on assets (ROA)13.6%within the sector's middle half-14.5%within the sector's middle half▲ 0.8pp12.3%within the sector's middle half▼ 2.2pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €272,657
Fixed assets €167,706 ▼ 26.3%
Current assets €104,952 ▲ 88.6%
Equity and liabilities €272,657
Equity €110,096 ▲ 43.7%
Debt €162,562 ▼ 21.3%
Debt's share of the balance-sheet total falls from 72.9% to 59.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€73,869▼
2024 · €88,846
Cash flow
€57,664▼
2024 · €73,469
Debt to equity
1.48▼
2024 · 2.70
ROE
30.4%▼
2024 · 53.4%
Interest coverage
15.67▼
2024 · 20.60
Debt ≤ 1 year
€54,337▲
2024 · €44,982
Debt > 1 year
€108,225▼
2024 · €161,496
Income taxes
€11,500▲
2024 · €11,064
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€283,087€272,657▼
Fixed assets21/28€227,426€167,706▼
Intangible fixed assets21€173,315€153,315▼
Tangible fixed assets22/27€54,111€14,391▼
Furniture and vehicles24€47,865€5,690▼
Other tangible fixed assets26€6,247€8,701▲
Current assets29/58€55,661€104,952▲
Amounts receivable within one year40/41€6,936€6,936=
Other amounts receivable41€6,936€6,936=
Current investments50/53-€9,000
Cash at bank and in hand54/58€15,458€40,123▲
Deferred charges and accrued income490/1€33,266€48,893▲
Equity and liabilities
Total equity and liabilities10/49€283,087€272,657▼
Equity10/15€76,609€110,096▲
Contributions10/11€4,000€4,000=
Profit (loss) carried forward14€72,609€106,096▲
Amounts payable17/49€206,478€162,562▼
Amounts payable after more than one year17€161,496€108,225▼
Financial debts170/4€59,486€2,062▼
Other amounts payable178/9€102,010€106,163▲
Amounts payable within one year42/48€44,982€54,337▲
Current portion of amounts payable after more than one year42€33,443€24,207▼
Trade debts44€4,246€3,440▼
Suppliers440/4€4,246€3,440▼
Taxes, remuneration and social security45€0€1,250▲
Taxes450/3€0€1,250▲
Remuneration and social security454/9€0-
Other amounts payable47/48€7,294€25,440▲
Accrued charges and deferred income492/3€0-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32,540€24,177▼
Other operating charges640/8€1,399€3,349▲
Non-recurring operating charges66A-€20,570
Gross operating margin9900€90,245€97,788▲
Operating profit (loss)9901€56,306€49,692▼
Financial income75/76B€0€10▲
Recurring financial income75€0€10▲
Financial charges65/66B€4,313€4,715▲
Recurring financial charges65€4,313€4,715▲
Profit (loss) for the period before taxes9903€51,993€44,987▼
Income taxes67/77€11,064€11,500▲
Profit (loss) for the period9904€40,929€33,487▼
Profit (loss) for the period to be appropriated9905€40,929€33,487▼
Appropriation of the result
Profit (loss) to be appropriated9906€72,609€106,096▲
Profit (loss) brought forward from the previous period14P€31,680€72,609▲

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,357€32,540€24,177▼ 25.7%
Other operating charges640/8€591€1,399€3,349▲ 139%
Non-recurring operating charges66A--€20,570-
Gross operating margin9900€49,172€90,245€97,788▲ 8.4%
Operating profit (loss)9901€40,224€56,306€49,692▼ 11.7%
Financial income75/76B-€0€10▲ 200×
Recurring financial income75-€0€10▲ 200×
Financial charges65/66B€100€4,313€4,715▲ 9.3%
Recurring financial charges65€100€4,313€4,715▲ 9.3%
Profit (loss) for the period before taxes9903€40,124€51,993€44,987▼ 13.5%
Income taxes67/77€8,444€11,064€11,500▲ 3.9%
Profit (loss) for the period9904€31,680€40,929€33,487▼ 18.2%
Profit (loss) for the period to be appropriated9905€31,680€40,929€33,487▼ 18.2%
Line202320242025Change
Assets
Total assets20/58€232,231€283,087€272,657▼ 3.7%
Fixed assets21/28€197,438€227,426€167,706▼ 26.3%
Intangible fixed assets21€193,315€173,315€153,315▼ 11.5%
Tangible fixed assets22/27€4,123€54,111€14,391▼ 73.4%
Furniture and vehicles24€4,123€47,865€5,690▼ 88.1%
Other tangible fixed assets26-€6,247€8,701▲ 39.3%
Current assets29/58€34,793€55,661€104,952▲ 88.6%
Amounts receivable within one year40/41-€6,936€6,936=
Other amounts receivable41-€6,936€6,936=
Current investments50/53--€9,000-
Cash at bank and in hand54/58€4,838€15,458€40,123▲ 160%
Deferred charges and accrued income490/1€29,955€33,266€48,893▲ 47.0%
Equity and liabilities
Total equity and liabilities10/49€232,231€283,087€272,657▼ 3.7%
Equity10/15€35,680€76,609€110,096▲ 43.7%
Contributions10/11€4,000€4,000€4,000=
Profit (loss) carried forward14€31,680€72,609€106,096▲ 46.1%
Amounts payable17/49€196,551€206,478€162,562▼ 21.3%
Amounts payable after more than one year17€188,306€161,496€108,225▼ 33.0%
Financial debts170/4-€59,486€2,062▼ 96.5%
Other amounts payable178/9€188,306€102,010€106,163▲ 4.1%
Amounts payable within one year42/48€7,615€44,982€54,337▲ 20.8%
Current portion of amounts payable after more than one year42-€33,443€24,207▼ 27.6%
Trade debts44€3,281€4,246€3,440▼ 19.0%
Suppliers440/4€3,281€4,246€3,440▼ 19.0%
Taxes, remuneration and social security45€4,333€0€1,250-
Taxes450/3€1,944€0€1,250-
Remuneration and social security454/9€2,389€0--
Other amounts payable47/48-€7,294€25,440▲ 249%
Accrued charges and deferred income492/3€630€0--
Line202320242025Change
Profit (loss) for the period9904€31,680€40,929€33,487▼ 18.2%
+ Depreciation and write-downs630€8,357€32,540€24,177▼ 25.7%
Operating cash flow (approximation)€40,037€73,469€57,664▼ 21.5%
Investment in fixed assets (approximation)--€62,528€35,543-
Change in cash-€10,621€24,665▲ 132%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 18-08-2026 2026-00422084
31-12-2024 micro format 27-08-2025 2025-00409061
31-12-2023 micro format 09-07-2024 2024-00227618

Similar companies · same sector, comparable size

Of the 16,582 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,117. 6,533 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

MACQS was incorporated on 14 September 2023 as a private limited company.1 Total assets rose from €232,231 in 2023 to €272,657 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
18-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 18 days late
2025
31-12
Financial Equity above €100,000equity €110,096 ▲43.7%
A profit in every financial year since 2023 builds equity to €110,096.
27-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 27 days late
2024
31-12
Financial Highest result from 2023 to 2025net €40,929 ▲29.2%
Operating result €56,306, net result €40,929, both a record.
09-07
NBB filing Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded14-09-2023
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86995Nutrition and dietetics services
Contact
E-mail severine.macq@gmail.com
Phone +32486360562
E-invoicing
Reachable via Peppol
Peppol ID 0208:0805857390
Registered 27-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 25 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Jodoigne · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
2,232 m²
Building footprint
295 m²
Parcel 25048B0053/00Z000, Wallonia. Linked by address, not a title deed.
1 establishment unit
MACQS SRL
Chaussée de Tirlemont(Jod.) 74, 1370 JodoigneGeneral medical practice
since 2023unit no. 2.351.410.355
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25048B0053/00Z000 Wallonia 2,232 m² 1 · 295 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.